Approved in the US in 1999, oxcarbazepine is an anticonvulsant used as an adjunct and as monotherapy to treat partial seizures in adults and as an adjunct to treat partial seizures in children from ages 4 to 16 years (9) . The primary mechanism of action appears to be blockage of voltage-dependent sodium channels (9) . The drug is structurally related to carbamezapine but is not metabolized to the 10,11-epoxide, which lessens the incidence of side effects associated with carbamezapine (10) . Studies have shown oxcarbazepine to be as effective and better tolerated by patients having difficulties with carbamezapine, although this observation pertains to patients with epilepsy (10) . Although hematologic and hepatic toxicity have not been reported, hyponatremia has been associated with oxcarbazepine (9) . Common side effects related to oxcarbazepine use appear to be dosage-related and include somnolence, dizziness, vomiting, and nausea (11) . Oxcarbazepine does not require serum monitoring (12); thus, frequent blood testing is not needed. Because this had been a factor in this patient's previous noncompliance, and because he had experienced a decrease in his PTSD symptoms while on carbamezapine, he was expected to do well on oxcarbazepine. As with all single-case reports, caution is advised in interpreting results; however, based on this case, further studies done in a controlled fashion may be warranted.
Timothy Berigan, DDS, MD Tucson, Arizona

Voice Mail as a Transitional Object in the Treatment of Borderline Personality Disorder
Dear Editor:
One of the psychodynamic theories related to borderline personality disorder (BPD) is that the patient was unable as a child to traverse the rapprochement subphase of the separation-individuation process described by Mahler. As a result, the patient was unable to develop a sense of emotional object constancy (1, 2) . Adler formulated such patient difficulties as an inability to maintain holding and soothing introjects when faced with separations (1). Winnicott described how children use transitional objects to help tolerate negative affects and aloneness until evocative memory is established (1). Psychiatric staff commonly observe an association between a diagnosis of BPD and the presence of transitional objects on the inpatient ward (3, 4) .
In therapy with patients having BPD, it is important to create a containing environment (1). This can help the patient manage anger and other painful feelings that are triggered by separations from the therapist and can lead to increasing suicidality (1). Adler describes the use of transitional objects to create a holding therapy environment (1). However, some therapists express concern that the use of transitional objects can be gratifying and promote regression and dependency.
As a junior resident working in therapy with a patient suffering from BPD, I was always unsettled by panicky phone calls. My patient, a First Nations woman who had experienced severe childhood abuse and neglect, sometimes called from a closet where she held a knife to her chest. I was surprised to find how little intervention it took to settle the situation: it seemed that just hearing my voice was enough. Later in therapy, I acquired voice mail. She confessed to me that she frequently called my voice mail between sessions to hear my voice and that this helped her. Since that experience, I have had several other patients with BPD who have used voice mail in this way. Some find the experience "grounding," while others find that it reinforces my role as the caring therapist.
Voice mail is a standard way of receiving messages that can provide a personal message 24 hours daily, 7 days a week. It is not a gift for the patient, nor is it created especially for the patient. There is no limit to the length of the message left. Conversely, the caller can choose not to leave a message, and the receiver will be unaware of the call. Patients can be warned that there may be a variable delay before a call is returned, and other plans for access to immediate resources can be discussed, as appropriate. The use of voice mail by a patient with BPD in some ways mimics the rapprochement phase, because the patient can use the therapist's voice as a way of checking back and "refuelling" between sessions. However, voice mail does not gratify the patient with the therapist's presence. Moreover, use of voice mail can be explored within therapy sessions.
In therapy with patients having BPD, voice mail is a tool that can assist in containing, soothing, and holding strong emotions. With this tool, crisis phone calls, emergency room visits, and selfharming gestures may be reduced.
Critical Appraisal of Extended Treatment Studies in Attention-Deficit Hyperactivity Disorder
Russell Schachar and colleagues' excellent review (1) offers a sobering and necessary balance that illustrates the current limitations of our knowledge regarding treatment effects in attention-deficit hyperactivity disorder (ADHD). With regard to the combination of pharmacologic and nonpharmacologic treatment approaches, it is instructive to note that the literature does not address an important practical issue for children responding to short-term stimulants in the classroom. We know that most treatment studies have found positive benefit for short-acting stimulants, even though these medications give a benefit for only 90 minutes, approximately. Why these short-acting medications work as well as they do throughout the school day, given their short duration of action, is an important and relatively unexplored question.
A recent article on impulse disorders casts light on this question (2) . In it, Strayhorn makes the point that one aspect of working with impulse disorders concerns facilitating the development of "a positive momentum." Perhaps this is an important clue as to why the short-acting medications work as well as they do. In theory, the longer-acting stimulants provide better coverage throughout the school day; however, many children do receive good benefit from short-acting preparations-a seeming paradox. This suggests that the sustained action of these short-acting medications might be explained in terms of the development of positive momentum. If children with ADHD "get on track" for 90 minutes at the beginning of the morning and afternoon school, their positive momentum may carry them along for the remaining time. If children are more able to achieve success in the class, albeit for a short period, their self-cognitions are more likely to be positive than negative. Perhaps this is the underlying mechanism behind the sustained benefit of short-acting medications beyond their pharmacologically effective time window. If so, facilitating positive momentum with cognitive and behavioural techniques begins to make more sense. The interaction wherein the pharmacologic effects of a short-acting stimulant allow the teacher to help the child get on a positive track may be a fruitful source of further research investigating how teachers can help children with ADHD enter the learning group.
Schachar's article notes that currently available randomized treatment studies have some significant limitations regarding the wide array of outcomes that are important to measure for children and adolescents with this common disorder. An important and underexplored outcome is related to public health-driving safety and ADHD. Recent research emphasizes the increased risk of dangerous driving behaviour in young drivers with ADHD and other impulse disorders (3) . Ongoing research in this very important area of impulsivity and dangerous driving raises the possibility of identifying highrisk groups early and developing early preventive intervention strategies for an underrecognized public health issue.
Gabapentin-Induced Paradoxical Exacerbation of Psychosis in a Patient With Schizophrenia
Dear Editor:
Gabapentin is an anticonvulsant that is increasingly prescribed to patients with schizophrenia (1). Uses of anticonvulsants in this population have traditionally included antipsychotic augmentation and control of aggression and impulsivity (1) . Gabapentin is reported to have antianxiety and hypnotic effects in patients with schizophrenia (2) and panic disorder (3). Documented behavioural side effects include hypomanic and manic mood changes, aggression, and agitation (4-6). We report a case of paradoxical worsening psychosis associated with initiation of gabapentin in a patient with schizophrenia.
Mr A, aged 23 years, was diagnosed at age 18 years with schizophrenia according to DSM-IV criteria. He has permanent, full-time employment. His medications prior to starting gabapentin included clozapine 425 mg daily, procyclidine 10 mg daily, divalproex sodium 1000 mg daily, and fluoxetine 30 mg daily. He has been maintained on divalproex sodium since his initial presentation for affective symptoms. Fluoxetine was added to alleviate medicationinduced obsessive-compulsive symptoms. No recent medication changes have been made. His baseline psychotic symptomatolgy included rare paranoid
